- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TS-02-0006299

Medolife Pharmaceuticals Private Limited
About Medolife Pharmaceuticals Private Limited
Data last updated:
Medolife Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 14 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2020PTC143877.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rohini Chenna and Sankar Reddy Garem.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No 301 H.No 15 – 21 – 237/1 Balajinagar Sattenapalli Towers Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.26 Lakh, a decline of 52% compared to the previous year. For the same year it recorded a net loss of ₹48,798 (net margin -3.2%) and EBITDA of -₹48,798 (EBITDA margin -3.2%).
Medolife Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0006299).
Company details
Recognitions & Rankings of Medolife Pharmaceuticals
Contact details
Medolife Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressFlat No 301 H.No 15 – 21 – 237/1 Balajinagar Sattenapalli Towers Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medolife Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medolife Pharmaceuticals Private Limited, buy the company report.
Financials of Medolife Pharmaceuticals Private Limited
FY 2024 filings availableMedolife Pharmaceuticals Private Limited reported revenue of ₹15.26 Lakh (down 52% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 52% in the latest year. EBITDA fell 174% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹48,798 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹48,798 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -3.2% | |||
| Net Profit Margin | -3.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medolife Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medolife Pharmaceuticals Private Limited
Medolife Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohini Chenna | Director | 14 Aug 2024 | 2 Years 2 Months | Current |
| Sankar Reddy Garem Also directs: MNP Life Sciences Private Limited | Director | 14 Sep 2020 | 6 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Medolife Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medolife Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medolife Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medolife Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Subba Reddy Gummalla ceased to be Director on 02 Sep 2024.
Frequently asked questions
Medolife Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 14 September 2020 (6+ years old) and is registered under CIN U51909TG2020PTC143877.
Medolife Pharmaceuticals has 2 current directors:
- Rohini Chenna - Director
- Sankar Reddy Garem - Director
The latest financial statements of Medolife Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Medolife Pharmaceuticals is U51909TG2020PTC143877. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medolife Pharmaceuticals was incorporated on 14 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Subba Reddy Gummalla ceased to be Director on 02 Sep 2024. Rohini Chenna was appointed as Director on 14 Aug 2024. Sankar Reddy Garem was appointed as Director on 14 Sep 2020.
Yes, Medolife Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0006299).
The registered office of Medolife Pharmaceuticals is at Flat No 301 H.No 15 – 21 – 2371 Balajinagar Sattenapalli Towers Kukatpally, Hyderabad, Telangana, India – 500072.
Medolife Pharmaceuticals operates in the trading industry, in the specialty segment.
Medolife Pharmaceuticals can be reached at its registered office: Flat No 301 H.No 15 – 21 – 2371 Balajinagar Sattenapalli Towers Kukatpally, Hyderabad, Telangana, India – 500072.

